Výsledky vyhledávání - "Matthew Stankowicz"

Management of Chemotherapy-Induced Nausea and Vomiting with Trastuzumab Deruxtecan: A Case Series

Autor: Lauren Mauro, Kathleen K. Harnden, Matthew Stankowicz, Angela Pennisi

Publikováno v: Breast Care (Basel)

Introduction: Trastuzumab deruxtecan is a monoclonal antibody linked to a chemotherapy moiety that was recently approved by the Food and Drug Administration (FDA) for the treatment of metastatic human epidermal growth factor receptor 2 (HER2) positiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4eb74370a7b24d900eedc2049e22bd
https://europepmc.org/articles/PMC8436604/

Zobrazit plný text záznamu

Risk of Cancer-Associated Thrombosis and Bleeding in Veterans With Malignancy Who Are Receiving Direct Oral Anticoagulants

Autor: Matthew, Stankowicz, Megan, Banaszynski, Russell, Crawford

Publikováno v: Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 35(Suppl 4)

The low incidence of venous thromboembolism formation in this study and similar rates of bleeding in other clinical trials indicate that direct oral anticoagulant agents are safe alternatives in patients with cancer.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fc9c85c4d4533a6099986fd966609a0f
https://pubmed.ncbi.nlm.nih.gov/30766398

Zobrazit plný text záznamu

Retrospective evaluation of clinical evidence submitted with off-label requests at a community-based oncology infusion center

Autor: Matthew Stankowicz, David M. Heyer

Publikováno v: Journal of Clinical Oncology. 37:254-254

254 Background: A systematic grading system was created to evaluate literature submitted with off-label requests to the Inova Schar Cancer Institute (ISCI) oncology P&T. Level of evidence (LOE) 1A, 1B, and 1C are granted immediate approval. LOE 2A, 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c6aa801dd81c86917f3f18ef0efe1e0d
https://doi.org/10.1200/jco.2019.37.27_suppl.254

Zobrazit plný text záznamu

Clinical pharmacogenomic testing impacts therapy decisions and supportive medication choices in breast cancer

Autor: Matthew Stankowicz, Ramaswamy K. Iyer, John F. Deeken, Brittany Vogt, Scott D. Barnett, Andrea Solares, Kathleen Kiernan Harnden, Arielle Stafford, Costanza Cocilovo, Grace Lawrence, Franziska Moeckel, Sheila Philips, Kirsten H. Edmiston, Alina Khromykh

Publikováno v: Journal of Clinical Oncology. 37:569-569

569 Background: Pharmacogenomics, the study of the interaction between the patient’s genome and therapeutic drug response, evaluates the associations between efficacy and toxicity through analysis of drug metabolizing enzymes. As personalized medic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::33ddc851e0037039c75b81f539a653b7
https://doi.org/10.1200/jco.2019.37.15_suppl.569

Zobrazit plný text záznamu